Literature DB >> 1979583

Thymic stromal cell clone with nursing activity supports the growth and differentiation of murine CD4+8+ thymocytes in vitro.

T Nishimura1, Y Takeuchi, Y Ichimura, X H Gao, A Akatsuka, N Tamaoki, H Yagita, K Okumura, S Habu.   

Abstract

Thymic stromal cell clone, TNC-R3.1 cell, was established from spontaneous AKR/J mouse thymoma. TNC-R3.1 cell, which has the similar properties to thymic nurse cells, formed a unique complex with normal thymocyte subpopulations. Flow cytometry analysis demonstrated that CD4+8+ and CD4-8- immature thymocytes preferentially interacted with TNC-R3.1 stromal cell clone. CD4+8+ thymocytes, which interacted with TNC-R3.1 stromal cell clone, contained a higher proportion of large size and cycling T cells than did noninteracting CD4+8+ thymocytes. As is generally accepted, CD4+8+ thymocytes did not respond to any stimulation such as IL-2, anti-CD3 mAb (2C11), or IL-2 plus 2C11. However, culture of isolated CD4+8+ thymocytes on TNC-R3.1 stromal cell monolayer in the presence of suboptimal dose of IL-2 induced a significant cell growth. Moreover, the addition of 2C11 and IL-2 into this coculture system resulted in a dramatic increase of the proliferative response of thymocytes. Flow cytometry analysis showed the proliferating cells on TNC-R3.1, which originated from CD4+8+ thymocytes, were mostly TCR-alpha beta+ CD3+CD4-8+ T cells. These results provide in vitro evidence that CD4+8+ thymocytes are at an intermediate stage of T cell maturation and TNC-R3.1 stromal cell clone induces the growth and differentiation of CD4+8+ thymocytes into CD4-8+ T cells.

Entities:  

Mesh:

Year:  1990        PMID: 1979583

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  8 in total

Review 1.  Questionable thymic nurse cell.

Authors:  M Pezzano; M Samms; M Martinez; J Guyden
Journal:  Microbiol Mol Biol Rev       Date:  2001-09       Impact factor: 11.056

2.  Cellular and peptide requirements for in vitro clonal deletion of immature thymocytes.

Authors:  K Iwabuchi; K Nakayama; R L McCoy; F Wang; T Nishimura; S Habu; K M Murphy; D Y Loh
Journal:  Proc Natl Acad Sci U S A       Date:  1992-10-01       Impact factor: 11.205

3.  Adhesion molecules involved in the binding and subsequent engulfment of thymocytes by a rat thymic epithelial cell line.

Authors:  M Colić; D Vucević; M Miyasaka; T Tamatani; M D Pavlović; A Dujić
Journal:  Immunology       Date:  1994-11       Impact factor: 7.397

4.  Epithelial V-like antigen (EVA), a novel member of the immunoglobulin superfamily, expressed in embryonic epithelia with a potential role as homotypic adhesion molecule in thymus histogenesis.

Authors:  M Guttinger; F Sutti; M Panigada; S Porcellini; B Merati; M Mariani; T Teesalu; G G Consalez; F Grassi
Journal:  J Cell Biol       Date:  1998-05-18       Impact factor: 10.539

5.  Requirement for VLA-4 and VLA-5 integrins in lymphoma cells binding to and migration beneath stromal cells in culture.

Authors:  K Miyake; Y Hasunuma; H Yagita; M Kimoto
Journal:  J Cell Biol       Date:  1992-11       Impact factor: 10.539

6.  Large-scale culture system of human CD4+ helper/killer T cells for the application to adoptive tumour immunotherapy.

Authors:  Y Nakamura; Y Tokuda; M Iwasawa; H Tsukamoto; M Kidokoro; N Kobayashi; S Kato; T Mitomi; S Habu; T Nishimura
Journal:  Br J Cancer       Date:  1992-07       Impact factor: 7.640

7.  Murine asialo GM1+CD8+ T cells as novel interleukin-12-responsive killer T cell precursors.

Authors:  U Lee; K Santa; S Habu; T Nishimura
Journal:  Jpn J Cancer Res       Date:  1996-05

8.  Expression of tumor-associated glycoantigen, sialyl Lewis(a), in human head and neck squamous cell carcinoma and its application to tumor immunotherapy.

Authors:  K Makino; T Ogata; H Miyake; S Habu; T Nishimura
Journal:  Jpn J Cancer Res       Date:  1994-09
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.